Senior Scientist – Biophysical Attribute Sciences (Analytical Operations, Process Development)
on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system...
on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system...
and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR...
and take a key role in the ongoing development, operations, and scaling of our Trusted Container Registry (TCR) platform. TCR... Responsibilities Build, operate, and improve the Trusted Container Registry (TCR) and its supporting services. Develop automation...
cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors...
on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system...
Title: Personalized TCR-T Team Lead Location: Upper East Side Org Unit: MCC Laboratories Work Days: Weekly... and driving a cutting-edge research group and platform for personalized TCR-based cell therapies targeting autologous tumors. The...
the engineering, process development, and translational advancement of TCR engineered T cell therapies from candidate... of next-generation TCR-T cell therapies incorporating viral and non-viral ex vivo engineering as well as in vivo T cell therapy...
. Repertoire is advancing a pipeline of TCR bispecific immunotherapies with the potential to address a broad range of cancers... and autoimmune disorders. The company’s lead oncology program, RPTR-1-201, a TCR bispecific, is currently in a Phase 1/2 clinical...
is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune...
alliance management strategies for key CDMO partnerships Lead sourcing and negotiation for Auto TCR-T, Allo CAR-T... cost, quality, and relationship dynamics Experience with novel modalities (CAR-T, TCR-T, in-vivo gene editing) Track...